Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
drug metabolite |
| gptkbp:CASNumber |
138694-78-1
|
| gptkbp:drugClass |
antihistamine
norepinephrine reuptake inhibitor partial agonist at 5-HT1A receptor antagonist at 5-HT2A receptor antagonist at H1 receptor antagonist at alpha-1 adrenergic receptor antagonist at alpha-2 adrenergic receptor |
| gptkbp:eliminationHalfLife |
urine
feces |
| gptkbp:hasMolecularFormula |
C17H19N3O2S
|
| https://www.w3.org/2000/01/rdf-schema#label |
norquetiapine
|
| gptkbp:is_active_metabolite_of |
gptkb:quetiapine
|
| gptkbp:IUPACName |
11-[4-(2-hydroxyethoxy)-1-piperazinyl]dibenzo[b,f][1,4]thiazepine
|
| gptkbp:metabolism |
gptkb:quetiapine
|
| gptkbp:molecularWeight |
329.42 g/mol
|
| gptkbp:PubChem_CID |
3083541
CHEMBL2105707 |
| gptkbp:UNII |
6QX1Q1E0HC
|
| gptkbp:bfsParent |
gptkb:quetiapine
|
| gptkbp:bfsLayer |
6
|